Syndax Pharmaceuticals Inc expected to post a loss of $1.11 a share - Earnings Preview

Syndax Pharmaceuticals

02/11/2024 04:09

* Syndax Pharmaceuticals Inc  SNDX.OQ   SNDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 5 for the period ending September 30 2024
    * The Waltham Massachusetts-based  company is expected to
report
revenue of $11.199 million, according to the mean estimate from
9 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Syndax Pharmaceuticals
Inc is
for a loss of $1.11 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is 35.00​, above​ its last closing price
of $18.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.91       -0.91      -0.80     Beat    12.5
 Mar. 31 2024  -0.96       -0.98      -0.85     Beat    13.1
 Dec. 31 2023  -0.97       -0.99      -1.00     Missed  -0.6​
 Sep. 30 2023  -0.80       -0.80      -0.73     Beat    8.2
 ​​Jun.        -0.73       -0.73      -0.64     Beat    12.6
 30 2023                                                
 Mar. 31 2023  -0.60       -0.60      -0.59     Beat    1​
 Dec. 31 2022  -0.65       -0.65      -0.62     Beat    4.4
 Sep. 30 2022  -0.64       -0.63      -0.58     Beat    8.7
 This summary was machine generated November 2 at 04:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)